Skip to main content

Gastric Balloon

Gastric Balloon in Turkey

Gastric balloon in Turkey is a temporary, non-surgical obesity treatment that places a space-occupying device inside the stomach. Many systems use endoscopic placement, although device designs and removal requirements differ. The balloon does not remove stomach tissue or reroute the intestine.

What Is a Gastric Balloon and How Is It Different From Bariatric Surgery?

A gastric balloon is a temporary stomach device and does not surgically remove or bypass gastrointestinal tissue. Many intragastric balloons enter through the mouth during an endoscopic procedure. The device then occupies space inside the stomach and can contribute to earlier fullness. It is intended to accompany changes in eating patterns and physical activity. Gastric sleeve surgery permanently removes stomach tissue. Gastric bypass also changes the route food follows through the intestine. A balloon therefore creates a fundamentally different treatment pathway. Removal requirements, device design, medical eligibility, and continuing obesity management should be discussed before placement.

A gastric balloon is a temporary stomach device and does not surgically remove or bypass gastrointestinal tissue. Many intragastric balloons enter through the mouth during an endoscopic procedure. The device then occupies space inside the stomach and can contribute to earlier fullness. It is intended to accompany changes in eating patterns and physical activity. Gastric sleeve surgery permanently removes stomach tissue. Gastric bypass also changes the route food follows through the intestine. A balloon therefore creates a fundamentally different treatment pathway. Removal requirements, device design, medical eligibility, and continuing obesity management should be discussed before placement.

Who May Be Considered for a Gastric Balloon in Turkey?

Gastric balloon treatment may be considered after clinical assessment confirms that an endoscopic obesity treatment fits the individual patient.

  • BMI assessment: Turkey's 2026 protocol includes defined BMI criteria for endoscopic obesity treatments.

  • Previous treatment: Earlier diet and physical-activity efforts form part of the assessment.

  • Comorbidities: Obesity-related diseases can influence eligibility when BMI falls within specified ranges.

  • Gastrointestinal history: Previous stomach surgery, ulcers, reflux, or other disorders may affect suitability.

  • Follow-up capacity: Patients need nutritional support, device monitoring, and a clear removal or completion plan.

The Turkish protocol requires individualized assessment rather than eligibility based on weight alone.

How Long Does a Gastric Balloon Stay in the Stomach?

A gastric balloon remains temporary, but the permitted treatment period depends on the specific device used. NIDDK describes endoscopically placed balloon systems requiring removal after approximately six months to one year. Individual manufacturer instructions can specify a shorter or longer maximum period within approved use. Patients should therefore obtain the exact device name and planned completion date before placement. A generic promise that every balloon remains for the same duration can be misleading. Follow-up should also address intolerance or complications requiring earlier removal. International patients need a removal plan that remains workable even after returning home.

What Symptoms Can Occur After Gastric Balloon Placement?

Nausea, vomiting, abdominal discomfort, and reduced food tolerance can occur after gastric balloon placement, particularly during early adaptation. Turkey's 2026 clinical protocol identifies nausea, vomiting, and abdominal pain among common intragastric balloon adverse events. Symptoms vary between patients and device types. Persistent vomiting can cause dehydration and may require medical treatment or earlier device removal. Severe or worsening abdominal pain requires assessment rather than assuming normal adaptation. Clinicians may use symptom-control medicines according to individual needs. International patients should receive written instructions explaining expected symptoms, hydration guidance, emergency warning signs, and who will manage problems after discharge.

Why Do Hyperinflation and Pancreatitis Matter With Some Gastric Balloons?

Spontaneous hyperinflation and acute pancreatitis are recognized complications associated particularly with liquid-filled intragastric balloon systems. The FDA continues to identify these risks in current weight-loss device guidance. Hyperinflation can produce abdominal enlargement, pain, vomiting, breathing difficulty, or worsening food intolerance. Pancreatitis can cause severe abdominal pain that may extend into the back. These symptoms can require urgent investigation and premature balloon removal. They should not be confused automatically with routine early nausea. Device-specific risks differ, so patients should know which balloon was inserted. Emergency clinicians should also be told that an intragastric balloon remains present.

What Do Turkey’s Current Rules Say About Gastric Balloon Treatment?

Turkey regulates gastric balloon care within its broader obesity-treatment and healthcare-service framework. The April 2026 Ministry clinical protocol classifies intragastric balloons as endoscopic bariatric and metabolic treatments. It separates these treatments from bariatric surgery and defines clinical selection criteria for endoscopic methods. The November 2025 obesity regulation also defines registered obesity units as multidisciplinary services providing non-surgical obesity care. Healthcare promotion must separately follow the November 2025 advertising regulation. That regulation prohibits overt or covert healthcare advertising and misleading superiority claims. These rules establish service and information standards but do not guarantee individual treatment outcomes.

What Happens After a Gastric Balloon Is Removed?

After gastric balloon removal, long-term obesity management remains necessary because the temporary device no longer occupies stomach space. NIDDK describes balloons as temporary devices used alongside eating and physical-activity changes. Removing the balloon does not permanently alter stomach anatomy. Appetite, eating patterns, medicines, metabolic disease, and lifestyle can continue influencing body weight afterward. Patients may therefore need nutritional counseling, obesity medicine, behavioral support, or another treatment strategy. Further procedures should follow a new clinical assessment rather than automatic escalation. International patients should arrange continuing obesity care before leaving Turkey, especially when their balloon removal occurs in another country.

What Should International Patients Verify Before a Gastric Balloon in Turkey?

International patients should verify the provider, exact balloon system, treatment plan, and emergency arrangements before traveling for gastric balloon treatment.

  • Check the Ministry of Health's current international health-tourism authorized-provider records.

  • Ask for the exact balloon device, planned placement period, and removal requirements.

  • Provide previous endoscopy, stomach surgery, reflux, ulcer, medication, and relevant medical information.

  • Confirm who will manage persistent vomiting, abdominal pain, dehydration, or suspected balloon complications.

  • Arrange nutritional follow-up and confirm where balloon removal will occur if it requires a separate procedure.

The Ministry's authorized-provider page is dated July 28, 2026. Authorization does not guarantee individual suitability or outcomes.

Gastric Balloon in Turkey Cost 2026: What Affects the Total Cost?

Gastric balloon in Turkey has no single 2026 cost because device and clinical requirements vary between individual patients. This page therefore provides no fixed treatment price. Costs can depend on the balloon system, clinical assessment, endoscopy, sedation, placement, monitoring, and removal requirements. Medicines for nausea or reflux can add separate needs. Early removal, additional imaging, dehydration treatment, or other complication management can also change the financial plan. International patients should request an individualized written quotation after clinical review. The quotation should identify placement, removal, follow-up, medicines, emergency care arrangements, and excluded services clearly.

This content provides general medical information and does not recommend a gastric balloon, specific device, healthcare provider, or clinical outcome. Obesity treatment requires individualized assessment by appropriately qualified healthcare professionals.

Last updated: August 14, 2026

Sources

  • https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/types

  • https://www.fda.gov/medical-devices/letters-health-care-providers/fda-alerts-health-care-providers-about-potential-risks-liquid-filled-intragastric-balloons

  • https://www.fda.gov/media/191489/download

  • https://shgm.saglik.gov.tr/TR-117695/obezite-ve-metabolik-cerrahi-klinik-protokolu-2026-guncellendi-ve-yayimlandi.html

  • https://antalyaism.saglik.gov.tr/TR-366499/obezite-uniteleri-ve-obezite-cerrahisi-uygulama-uniteleri--hakkinda-yonetmelik.html

  • https://etimesgutdh.saglik.gov.tr/TR-920305/endoskopi-ve-kolonoskopi-unitesi.html

  • https://shgmturizmdb.saglik.gov.tr/EN-69061/authorized-healthcare-providers-and-facilitators.html

  • https://shgmturizmdb.saglik.gov.tr/EN-108974/regulation-on-international-health-tourism-and-tourist-health.html

  • https://antalyaism.saglik.gov.tr/TR-366500/saglik-hizmetlerinde-tanitim-ve-bilgilendirme--faaliyetleri-hakkinda-yonetmelik.html